Neuro-Adaptive Shunt Systems for Personalized Cardiovascular Care
Legal Citation
Summary of the Inventive Concept
The present inventive concept discloses a next-generation implantable shunt system that leverages advancements in artificial intelligence, micro-robotics, and bio-hybrid technologies to provide real-time, adaptive fluid flow management for cardiovascular disease treatment.
Background and Problem Solved
The original patent addressed the need for invasive adjustment systems for implantable medical devices. However, these systems have limitations in terms of their invasiveness, lack of real-time adaptability, and limited functionality. The new inventive concept solves these problems by introducing a neuro-adaptive shunt system that can predict optimal fluid flow rates, non-invasively reconfigure the shunt, and perform self-maintenance tasks.
Detailed Description of the Inventive Concept
The neuro-adaptive shunt system comprises a neural network-based control module that predicts optimal fluid flow rates based on real-time physiological data. This prediction is used to adjust the flowpath of the implanted shunt via a shape-memory actuation component. The system can be non-invasively reconfigured using electromagnetic signals, and a micro-robotic system can navigate through the shunt's flowpath to perform maintenance tasks. Additionally, the shunt system can be integrated with living tissue-engineered components that adapt to changing physiological conditions, and a cloud-based platform enables remote monitoring and adjustment of the shunt settings.
Novelty and Inventive Step
The new inventive concept's novelty lies in its integration of AI, micro-robotics, and bio-hybrid technologies to create a real-time, adaptive fluid flow management system. The inventive step is the introduction of a neuro-adaptive control module that predicts optimal fluid flow rates and adjusts the shunt's flowpath accordingly, enabling personalized cardiovascular care.
Alternative Embodiments and Variations
Alternative embodiments may include using different types of sensors or data sources for the neural network-based control module, varying the design of the micro-robotic system, or integrating the shunt system with other implantable devices. Variations may include using different materials or geometries for the shunt body or adapting the system for use in other medical applications.
Potential Commercial Applications and Market
The neuro-adaptive shunt system has significant commercial potential in the cardiovascular disease treatment market, with potential applications in hospitals, clinics, and remote healthcare settings. The system's ability to provide personalized, real-time fluid flow management could improve patient outcomes, reduce healthcare costs, and increase market share for manufacturers and healthcare providers.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61B17/12177 |
| A | A61 | A61B17/11 |
| A | A61 | A61B17/1204 |
| A | A61 | A61B17/12109 |
| A | A61 | A61M27/002 |
| A | A61 | A61M2205/04 |
| A | A61 | A61M2205/3331 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device engineering, specifically implantable fluid management systems, cardiovascular interventional technologies, with expertise in shape memory materials, minimally invasive adjustment techniques, and biomedical device design
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer with advanced degree, 5-7 years experience in medical device design, familiar with implantable device technologies, shape memory alloys, micro-robotic systems, and adaptive medical technologies
Obviousness Rationale
A PHOSITA would recognize that the PTD's neural network-based adaptive shunt system represents a predictable technological evolution of the source patent's adjustable implantable device framework. The core mechanical principles of shape memory actuation and minimally invasive adjustment are directly extended through computational intelligence and sensor integration. The variations represent incremental improvements using known techniques in medical device design, specifically applying machine learning and micro-robotic technologies to existing implantable device adjustment methodologies.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,197 |
|---|---|
| Title | Adjustable implantable devices and associated methods |
| Assignee(s) | Shifamed Holdings, LLC |